Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[$lucd](/topic/$lucd)

### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$lucd/c:line/m:sentiment.svg)  
[Sentiment 24-Hour Chart Data](/topic/$lucd/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Month**: XX% -X%  
**1-Year High**: XXX% on 2025-04-30  
**1-Year Low**: XX% on 2025-05-22  

**Most Supportive Themes**
- **Positive Trading Experiences:** (50%) Many users are sharing positive experiences and profits from trading $LUCD, often mentioning specific strategies and advisors.
- **Coverage Determination:** (25%) News of an expert medical panel convened by MolDX regarding Medicare coverage for Lucid Diagnostics' EsoGuard test is circulating.
  
**Most Critical Themes**
- **Financial Concerns:** (25%)  Concerns about Lucid Diagnostics' financial health and potential dilution of shares are being discussed.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %  |
| ------- | -------- | -   | ------- | -   | -------- | -  |
| X       | XXX      | XX% | XXX     | XX% | XX       | X% |
|         |          |     |         |     |          |    |
| Total   | XXX      | XX% | XXX     | XX% | XX       | X% |

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

$lucd

Sentiment: XX%

Sentiment Line Chart
Sentiment 24-Hour Chart Data
Current Value: XX%
Daily Average: XX%
1 Month: XX% -X%
1-Year High: XXX% on 2025-04-30
1-Year Low: XX% on 2025-05-22

Most Supportive Themes

  • Positive Trading Experiences: (50%) Many users are sharing positive experiences and profits from trading $LUCD, often mentioning specific strategies and advisors.
  • Coverage Determination: (25%) News of an expert medical panel convened by MolDX regarding Medicare coverage for Lucid Diagnostics' EsoGuard test is circulating.

Most Critical Themes

  • Financial Concerns: (25%) Concerns about Lucid Diagnostics' financial health and potential dilution of shares are being discussed.

Network engagement breakdown:

Network Positive % Neutral % Negative %
X XXX XX% XXX XX% XX X%
Total XXX XX% XXX XX% XX X%
$lucd Sentiment
/topic/$lucd/sentiment